Trial Design Challenges

• Heterogeneity of population

• Identification of acceptable comparators

• Defining endpoint that is clinically-relevant and achievable

• Consideration for additional dose finding

• Complicated safety assessments

Previous slide

Next slide

Back to first slide

View graphic version